Golden State Medical Supply Recalls Tramadol Tablets Due to Labeling Error
Golden State Medical Supply is recalling Tramadol Hydrochloride 50 mg tablets because the patient leaflets contain incorrect dosing instructions for unscored tablets.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates a low risk of adverse health consequences. The issue is a minor labeling error regarding dosing instructions for unscored tablets, fitting the criteria for a Low severity score.
Plain-English summary
Golden State Medical Supply Inc. is recalling specific lots of Tramadol Hydrochloride Tablets, USP, 50 mg, Rx Only. The affected products are 100-count and 500-count bottles manufactured by Teva Czech Industries, s.r.o. and packaged by GSMS Incorporated. The recall covers 379,043 100-count bottles and 330,997 500-count bottles distributed nationwide in the USA.
The recall was initiated due to a labeling error. The patient leaflets included with the specified lots of unscored tablets contain language regarding a 25 mg dosing titration that requires the use of a scored 50 mg tablet. Since the recalled tablets are unscored, the instructions are incorrect for this specific product form.
Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed in the recall notice. If the product matches the recalled lots, it should be returned to the supplier or disposed of according to local regulations. No adverse health consequences are expected from this labeling error.
The recalled product
- Product
- TRAMADOL HYDROCHLORIDE Tablets, USP, 50 mg, Rx Only a)100-count bottles (NDC 60429-588-01) b) 500-count bottle (NDC 60429-588-05) Manufactured by Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Packaged by GSMS Incorporated, Camarillo, CA 93012
- Manufacturer
- Golden State Medical Supply Inc.
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot Numbers: a) GS021259
- Exp. Date 11/31/2019
- GS021742
- GS022074
- Exp. 2/29/2020
- GS022619
- GS022836
- 3/31/2020
- GS023243
- GS023631
- Exp. 4/30/2020
- GS023869
- GS024562
- GS025492
- Exp. 5/31/2020
- GS025184
- Exp. 6/30/2020
- GS026306
- Exp. 9/30/2020
- GS026654
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Golden State Medical Supply Inc.
See all →- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighBaclofen tablet bottles recalled over the presence of foreign tablets
FDA (Drugs) · 2025-12-24
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02